{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:16:06Z","timestamp":1789013766245,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03200-4","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:34:01Z","timestamp":1761410041000},"page":"1003-1010","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence, demographics, and mortality\/morbidity of thrombotic events: A nationwide study of SLE patients in the United States"],"prefix":"10.1007","volume":"59","author":[{"given":"Sachi","family":"Singhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Jotwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakhyath","family":"Srikaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devashish","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Styler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"key":"3200_CR1","doi-asserted-by":"crossref","unstructured":"Tassiulas IO, Boumpas DT (2009) Clinical features and treatment of systemic lupus erythematosus In: Firestein GS, Budd RC, Harris ED, Jr, McInnes IB, Ruddy S, Sergent JS eds. Textbook of Rheumatology","DOI":"10.1016\/B978-1-4160-3285-4.10075-0"},{"key":"3200_CR2","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3899\/jrheum.150506","volume":"43","author":"A Hinojosa-Azaola","year":"2016","unstructured":"Hinojosa-Azaola A, Romero-Diaz J, Vargas-Ruiz AG et al (2016) Venous and arterial thrombotic events in systemic lupus erythematosus. J Rheumatol 43:576\u2013586. https:\/\/doi.org\/10.3899\/jrheum.150506","journal-title":"J Rheumatol"},{"key":"3200_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/art.21172","volume":"53","author":"A Afeltra","year":"2005","unstructured":"Afeltra A, Vadacca M, Conti L et al (2005) Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors. Arthritis Rheum 53:452\u2013459. https:\/\/doi.org\/10.1002\/art.21172","journal-title":"Arthritis Rheum"},{"key":"3200_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","volume":"82","author":"R Cervera","year":"2003","unstructured":"Cervera R, Khamashta MA, Font J et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 82:299\u2013308. https:\/\/doi.org\/10.1097\/01.md.0000091181.93122.55","journal-title":"Medicine"},{"key":"3200_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/RHU.0000000000000521","volume":"23","author":"S Annangi","year":"2017","unstructured":"Annangi S, Dammalapati TR, Nutalapati S et al (2017) Prevalence of pulmonary embolism among systemic lupus erythematosus discharges: a decade of analysis of the National hospital discharge survey. JCR J Clin Rheumatol 23:200\u2013206. https:\/\/doi.org\/10.1097\/RHU.0000000000000521","journal-title":"JCR J Clin Rheumatol"},{"key":"3200_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/s0049-0172(99)80003-1","volume":"28","author":"CA Peschken","year":"1999","unstructured":"Peschken CA, Esdaile JM (1999) Rheumatic diseases in North America\u2019s Indigenous peoples. Semin Arthritis Rheum 28:368\u2013391. https:\/\/doi.org\/10.1016\/s0049-0172(99)80003-1","journal-title":"Semin Arthritis Rheum"},{"key":"3200_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1191\/0961203306lu2305xx","volume":"15","author":"N Danchenko","year":"2006","unstructured":"Danchenko N, Satia JA, Anthony MS (2006) Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15:308\u2013318. https:\/\/doi.org\/10.1191\/0961203306lu2305xx","journal-title":"Lupus"},{"key":"3200_CR8","first-page":"339","volume":"53","author":"C Specker","year":"1994","unstructured":"Specker C, Becker A, Lakomek HJ et al (1994) [Systemic lupus erythematosus in men\u2013a different prognosis?]. Z Rheumatol 53:339\u2013345","journal-title":"Z Rheumatol"},{"key":"3200_CR9","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1177\/0961203311403640","volume":"20","author":"S Stefanidou","year":"2011","unstructured":"Stefanidou S, Benos A, Galanopoulou V et al (2011) Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year follow-up: a male:female comparison. Lupus 20:1090\u20131094. https:\/\/doi.org\/10.1177\/0961203311403640","journal-title":"Lupus"},{"key":"3200_CR10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1191\/0961203305lu2245oa","volume":"14","author":"MA Garcia","year":"2005","unstructured":"Garcia MA, Marcos JC, Marcos AI (2005) Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus 14:938\u2013946. https:\/\/doi.org\/10.1191\/0961203305lu2245oa","journal-title":"Lupus"},{"key":"3200_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932181","author":"S Truglia","year":"2022","unstructured":"Truglia S, Capozzi A, Mancuso S (2022) Relationship between gender differences and clinical outcome in patients with the antiphospholipid syndrome. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.932181","journal-title":"Front Immunol"},{"key":"3200_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/RHU.0b013e3181778ce0","volume":"14","author":"RG Lahita","year":"2008","unstructured":"Lahita RG (2008) Gender disparity in systemic lupus erythematosus, thoughts after the 8th international congress on systemic lupus Erythematosus, Shanghai, China, 2007. JCR J Clin Rheumatol 14:185\u2013187","journal-title":"JCR J Clin Rheumatol"},{"key":"3200_CR13","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1136\/ard.2005.040907","volume":"65","author":"E Krishnan","year":"2006","unstructured":"Krishnan E, Hubert HB (2006) Ethnicity and mortality from systemic lupus erythematosus in the US. Ann Rheum Dis 65:1500\u20131505. https:\/\/doi.org\/10.1136\/ard.2005.040907","journal-title":"Ann Rheum Dis"},{"key":"3200_CR14","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1183\/13993003.congress-2020.3449","volume":"56","author":"B Lazovic","year":"2020","unstructured":"Lazovic B, Sarac S, Milic R et al (2020) Prevalence of pulmonary embolism among systemic lupus erythematosus patients. Eur Respir J 56:3449. https:\/\/doi.org\/10.1183\/13993003.congress-2020.3449","journal-title":"Eur Respir J"},{"issue":"Suppl","key":"3200_CR15","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0049-3848(09)70136-7","volume":"123","author":"RH White","year":"2009","unstructured":"White RH, Keenan CR (2009) Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 123(Suppl):S11\u2013S17. https:\/\/doi.org\/10.1016\/S0049-3848(09)70136-7","journal-title":"Thromb Res"},{"key":"3200_CR16","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1161\/CIRCULATIONAHA.113.006472","volume":"129","author":"NA Zakai","year":"2014","unstructured":"Zakai NA, McClure LA, Judd SE et al (2014) Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation 129:1502\u20131509. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.006472","journal-title":"Circulation"},{"key":"3200_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/jth.12518","volume":"12","author":"W-S Chung","year":"2014","unstructured":"Chung W-S, Lin C-L, Chang S-N et al (2014) Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism: a nationwide cohort study. J Thromb Haemost 12:452\u2013458. https:\/\/doi.org\/10.1111\/jth.12518","journal-title":"J Thromb Haemost"},{"key":"3200_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10067-018-4336-3","volume":"38","author":"P Teh","year":"2019","unstructured":"Teh P, Zakhary B, Sandhu VK (2019) The impact of obesity on SLE disease activity: findings from the Southern California lupus registry (SCOLR). Clin Rheumatol 38:597\u2013600. https:\/\/doi.org\/10.1007\/s10067-018-4336-3","journal-title":"Clin Rheumatol"},{"key":"3200_CR19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/1756-185X.13153","volume":"20","author":"C Sun","year":"2017","unstructured":"Sun C, Qin W, Zhang Y-H (2017) Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: a meta-analysis. Int J Rheum Dis 20:917\u2013928. https:\/\/doi.org\/10.1111\/1756-185X.13153","journal-title":"Int J Rheum Dis"},{"key":"3200_CR20","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1001\/archinte.168.15.1678","volume":"168","author":"S Eichinger","year":"2008","unstructured":"Eichinger S, Hron G, Bialonczyk C et al (2008) Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med 168:1678\u20131683. https:\/\/doi.org\/10.1001\/archinte.168.15.1678","journal-title":"Arch Intern Med"},{"key":"3200_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","volume":"118","author":"PD Stein","year":"2005","unstructured":"Stein PD, Beemath A, Olson RE (2005) Obesity as a risk factor in venous thromboembolism. Am J Med 118:978\u2013980","journal-title":"Am J Med"},{"key":"3200_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.atherosclerosis.2012.05.033","volume":"223","author":"G Mazzoccoli","year":"2012","unstructured":"Mazzoccoli G, Copetti M, Dagostino MP (2012) Epicardial adipose tissue and idiopathic deep venous thrombosis: an association study. Atherosclerosis 223:378\u2013383. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.05.033","journal-title":"Atherosclerosis"},{"key":"3200_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1055\/s-2005-871739","volume":"5","author":"JD Douketis","year":"2005","unstructured":"Douketis JD, Sharma AM (2005) Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction. Semin Vasc Med 5:25\u201333. https:\/\/doi.org\/10.1055\/s-2005-871739","journal-title":"Semin Vasc Med"},{"key":"3200_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/ard.51.2.147","volume":"51","author":"RA Asherson","year":"1992","unstructured":"Asherson RA, Cervera R (1992) The antiphospholipid syndrome: a syndrome in evolution. Ann Rheum Dis 51:147\u2013150. https:\/\/doi.org\/10.1136\/ard.51.2.147","journal-title":"Ann Rheum Dis"},{"key":"3200_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1136\/bmj.309.6949.239","volume":"309","author":"F Violi","year":"1994","unstructured":"Violi F, Ferro D, Basili S et al (1994) Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver. BMJ 309:239\u2013240. https:\/\/doi.org\/10.1136\/bmj.309.6949.239","journal-title":"BMJ"},{"key":"3200_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/0961203309360541","volume":"19","author":"M Petri","year":"2010","unstructured":"Petri M (2010) Update on anti-phospholipid antibodies in SLE: the Hopkins\u2019 lupus cohort. Lupus 19:419\u2013423. https:\/\/doi.org\/10.1177\/0961203309360541","journal-title":"Lupus"},{"key":"3200_CR27","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","volume":"74","author":"R Cervera","year":"2015","unstructured":"Cervera R, Serrano R, Pons-Estel GJ et al (2015) Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 74:1011\u20131018. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204838","journal-title":"Ann Rheum Dis"},{"key":"3200_CR28","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","volume":"175","author":"W Ageno","year":"2015","unstructured":"Ageno W, Riva N, Schulman S (2015) Long-term clinical outcomes of splanchnic vein thrombosis: results of an international registry. JAMA Intern Med 175:1474\u20131480. https:\/\/doi.org\/10.1001\/jamainternmed.2015.3184","journal-title":"JAMA Intern Med"},{"key":"3200_CR29","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","volume":"42","author":"G Saposnik","year":"2011","unstructured":"Saposnik G, Barinagarrementeria F, Brown RD et al (2011) Diagnosis and management of cerebral venous thrombosis. Stroke 42:1158\u20131192. https:\/\/doi.org\/10.1161\/STR.0b013e31820a8364","journal-title":"Stroke"},{"key":"3200_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.10.001","volume":"17","author":"M Wasay","year":"2008","unstructured":"Wasay M, Bakshi R, Bobustuc G et al (2008) Cerebral venous thrombosis: analysis of a multicenter cohort from the united States. J Stroke Cerebrovasc Dis 17:49\u201354. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2007.10.001","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"3200_CR31","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","volume":"35","author":"JM Ferro","year":"2004","unstructured":"Ferro JM, Canh\u00e3o P, Stam J et al (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke 35:664\u2013670","journal-title":"Stroke"},{"key":"3200_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1600-0404.1999.tb00669.x","volume":"99","author":"R Christopher","year":"1999","unstructured":"Christopher R, Nagaraja D, Dixit NS et al (1999) Anticardiolipin antibodies: a study in cerebral venous thrombosis. Acta Neurol Scand 99:121\u2013124","journal-title":"Acta Neurol Scand"},{"key":"3200_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/ajh.10103","volume":"70","author":"T Bombeli","year":"2002","unstructured":"Bombeli T, Basic A, Fehr J (2002) Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol 70:126\u2013132","journal-title":"Am J Hematol"},{"key":"3200_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/00000658-198710000-00013","volume":"206","author":"JL Mills","year":"1987","unstructured":"Mills JL, Friedman EI, Taylor LMJ (1987) Upper extremity ischemia caused by small artery disease. Ann Surg 206:521\u2013528. https:\/\/doi.org\/10.1097\/00000658-198710000-00013","journal-title":"Ann Surg"},{"key":"3200_CR35","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/art.21314","volume":"53","author":"ZS Sarabi","year":"2005","unstructured":"Sarabi ZS, Chang E, Bobba R (2005) Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus. Arthritis Rheum 53:609\u2013612. https:\/\/doi.org\/10.1002\/art.21314","journal-title":"Arthritis Rheum"},{"key":"3200_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2230.2011.04266.x","volume":"37","author":"N Ezra","year":"2012","unstructured":"Ezra N, Jorizzo J (2012) Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus. Clin Exp Dermatol 37:327\u2013334. https:\/\/doi.org\/10.1111\/j.1365-2230.2011.04266.x","journal-title":"Clin Exp Dermatol"},{"key":"3200_CR37","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1056\/NEJM199506293322607","volume":"332","author":"JW Rich-Edwards","year":"1995","unstructured":"Rich-Edwards JW, Manson JE, Hennekens CH et al (1995) The primary prevention of coronary heart disease in women. N Engl J Med 332:1758\u20131766","journal-title":"N Engl J Med"},{"key":"3200_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11739-008-0209-0","volume":"4","author":"M Bazzan","year":"2009","unstructured":"Bazzan M, Vaccarino A (2009) Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies: only in selected, high risk patients. Intern Emerg Med 4:61\u201362. https:\/\/doi.org\/10.1007\/s11739-008-0209-0","journal-title":"Intern Emerg Med"},{"key":"3200_CR39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.autrev.2013.10.014","volume":"13","author":"L Arnaud","year":"2014","unstructured":"Arnaud L, Mathian A, Ruffatti A (2014) Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. Autoimmun Rev 13:281\u2013291. https:\/\/doi.org\/10.1016\/j.autrev.2013.10.014","journal-title":"Autoimmun Rev"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03200-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03200-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03200-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:32:33Z","timestamp":1781339553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03200-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3200"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03200-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7015967\/v1","asserted-by":"object"}]},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}